glp-1 receptor agonists and cancer risk in adults with obesity NEW: A systematic review found that #GLP1 have little or no effect on the for obesity-related cancers. The findings offer insights into the safety of GLP-1RAs suggest no GLP-1 Receptor Agonists for Obesity
Description
Am J Hematol
You may have seen Oprahs TV special about weight loss, or maybe you have a family member on one of these medications
Anti-inflammatory effects of exendin-4, a glucagon-like peptide-1 analog, on human peripheral lymphocytes in patients with type 2 diabetes
Marquez-Meneses JD, Olaya-Bonilla SA, Barrera-Carreo S, Tibaduiza-Arvalo LC, Forero-Crdenas S, Carrillo-Vaca L, Rojas-Rodrguez LC, Calderon-Ospina CA, Rodrguez-Quintana J
Historically, anti-obesity drugs have shown a lot of negative side effects and only moderate efficacy
